Draft guideline on the evaluation of medicinal products for the treatment of irritable bowel syndrome

  • Email
  • Help

Document details

Download document Draft guideline on the evaluation of medicinal products for the treatment of irritable bowel syndrome
Reference number CPMP/EWP/785/97 Rev. 1
Status draft: consultation open
First published 19/07/2013
Last updated 19/07/2013
Consultation start date 19/07/2013
Consultation end date 15/01/2014
Email address for submissions gastroenterologydg@ema.europa.eu

Summary

This guideline intends to address the European Union regulatory position in the main topics of clinical development of new medicinal products in the treatment of patients with irritable bowel syndrome.